Studies show new methods of diagnosis have slashed the risk of harm from unnecessary biopsies and cut deaths. Studies show new methods of diagnosis have slashed the risk of harm from unnecessary biopsies and cut deaths.
NHS guidance on prostate cancer tests slammed for being ‘outdated’ and costing thousands of lives each year
